Claude Labrie
Affiliations: | Universite Laval (Canada) |
Area:
Molecular Biology, Oncology, Cell BiologyGoogle:
"Claude Labrie"Children
Sign in to add trainee| Steeve Couillard | grad student | 2001 | Universite Laval (Canada) |
| Jacques Lapointe | grad student | 2001 | Universite Laval (Canada) (Chemistry Tree) |
| Heng Qi | grad student | 2002 | Universite Laval (Canada) |
| Mathias Leblanc | grad student | 2004 | Universite Laval (Canada) |
| Frederic Pouliot | grad student | 2004 | Universite Laval (Canada) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Labrie F, Archer DF, Bouchard C, et al. (2015) Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas. 81: 46-56 |
| Archer DF, Labrie F, Bouchard C, et al. (2015) Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). Menopause (New York, N.Y.) |
| Bouchard C, Labrie F, Archer DF, et al. (2015) Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy. Climacteric : the Journal of the International Menopause Society. 18: 590-607 |
| Labrie F, Archer D, Bouchard C, et al. (2014) Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. The Journal of Sexual Medicine. 11: 1766-85 |
| Choi J, Djebbar S, Fournier A, et al. (2014) The co-chaperone DNAJC12 binds to Hsc70 and is upregulated by endoplasmic reticulum stress. Cell Stress & Chaperones. 19: 439-46 |
| Labrie F, Martel C, Bérubé R, et al. (2013) Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens. The Journal of Steroid Biochemistry and Molecular Biology. 138: 359-67 |
| Labrie F, Archer DF, Bouchard C, et al. (2011) Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia. Climacteric : the Journal of the International Menopause Society. 14: 282-8 |
| Labrie F, Archer D, Bouchard C, et al. (2010) High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 26: 524-32 |
| Labrie F, Archer D, Bouchard C, et al. (2009) Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause (New York, N.Y.). 16: 897-906 |
| Labrie F, Archer D, Bouchard C, et al. (2009) Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause (New York, N.Y.). 16: 907-22 |